Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;29(1):65-75.
doi: 10.1177/0394632015615130. Epub 2015 Dec 10.

Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure

Affiliations

Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure

P Triggianese et al. Int J Immunopathol Pharmacol. 2016 Mar.

Abstract

Abnormalities in peripheral blood natural killer (NK) cells have been reported in women with primary infertility and recurrent spontaneous abortion (RSA) and several studies have been presented to define cutoff values for abnormal peripheral blood NK cell levels in this context. Elevated levels of NK cells were observed in infertile/RSA women in the presence of thyroid autoimmunity (TAI), while no studies have been carried out, to date, on NK cells in infertile/RSA women with non-autoimmune thyroid diseases. The contribution of this study is two-fold: (1) the evaluation of peripheral blood NK cell levels in a cohort of infertile/RSA women, in order to confirm related data from the literature; and (2) the assessment of NK cell levels in the presence of both TAI and subclinical hypothyroidism (SCH) in order to explore the possibility that the association between NK cells and thyroid function is not only restricted to TAI but also to SCH. In a retrospective study, 259 age-matched women (primary infertility [n = 49], primary RSA [n = 145], and secondary RSA [n = 65]) were evaluated for CD56+CD16+NK cells by flow cytometry. Women were stratified according to thyroid status: TAI, SCH, and without thyroid diseases (ET). Fertile women (n = 45) were used as controls. Infertile/RSA women showed higher mean NK cell levels than controls. The cutoff value determining the abnormal NK cell levels resulted ⩾15% in all the groups of women. Among the infertile/RSA women, SCH resulted the most frequently associated thyroid disorder while no difference resulted in the prevalence of TAI and ET women between patients and controls. A higher prevalence of women with NK cell levels ⩾15% was observed in infertile/RSA women with SCH when compared to TAI/ET women. According to our data, NK cell assessment could be used as a diagnostic tool in women with reproductive failure and we suggest that the possible association between NK cell levels and thyroid function can be described not only in the presence of TAI but also in the presence of non-autoimmune thyroid disorders.

Keywords: autoimmunity; infertility; natural killer cells; recurrent spontaneous abortion; thyroid.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Natural killer (NK) cell levels in the study population. Natural killer (NK) cell levels (as a percentage) in infertile women (n = 49) and in women with recurrent spontaneous abortion (RSA) (primary RSA, n = 145; secondary RSA, n = 65) compared with controls (n = 45). Horizontal lines indicate the mean values. Differences between mean values were determined by Student’s t-test. **P <0.01, ****P <0.001, in comparison with the controls.
Figure 2.
Figure 2.
Area under the curve (AUC) of the natural killer (NK) cell levels in the study groups. AUC of the NK cell levels (as a percentage) between the women with infertility and the controls (AUC 0.65, 95% CI 0.5–0.8) (a), women with primary recurrent spontaneous abortion (RSA) and the controls (AUC 0.7, 95% CI 0.6–0.7) (b), women with secondary RSA and the controls (AUC 0.7, 95% CI 0.6–0.7) (c). All the analyses showed a significance to discriminate women with infertility/RSA from the controls. *P <0.05; **P <0.01; ***P <0.001.
Figure 3.
Figure 3.
Prevalence of women with thyroid disorders in the study population. The prevalence of subclinical hypothyroidism (SCH) was significantly higher in the infertile (29/49, 59.2%, OR 3.7, 95% CI 1.6–8.6), primary RSA (RSA, 91/145, 62.7%, OR 4.3, 95% CI 2–8.7), and secondary RSA (39/65, 60%, OR 3.8, 95% CI 1.7–8.5) when compared with the comparison group (12/45, 27%). The prevalence of euthyroid (ET) women was higher in the comparison group (24/45, 53.4%) with respect to the other groups (infertile: 5/49, 10.2%, OR 0.1, 95% CI 0.04–0.3; primary RSA: 25/145, 17.2%, OR 0.2, 95% CI 0.08–0.3; secondary RSA: 9/65, 13.8%, OR 0.1, 95% CI 0.05–0.3). No differences in the prevalence of autoimmune thyroid diseases (TAI) occurred comparing groups (infertile: 15/49, 30.6%; primary RSA: 29/145, 20%; secondary RSA: 17/65, 26.2%; controls: 9/45, 20%). The contingency analyses were performed by Fisher’s test. **P <0.001; ***P <0.0001. The measure of association was obtained using OR, and CI was reported.

References

    1. Practice Committee of the American Society for Reproductive Medicine (2012) Evaluation and treatment of recurrent pregnancy loss: A committee opinion. Fertility and Sterility 98: 1103–1111. - PubMed
    1. Rai R, Regan L. (2006) Recurrent miscarriage. Lancet 368: 601–611. - PubMed
    1. Chen L, Quan S, Ou XH, et al. (2012) Decreased endometrial vascularity in patients with antiphospholipid antibodies associated recurrent miscarriage during midluteal phase. Fertility and Sterility 98: 1495–1502. - PubMed
    1. Bansal AS. (2010) Joining the immunological dots in recurrent miscarriage. American Journal of Reproductive Immunology 64: 307–315. - PubMed
    1. Saito S, Nakashima A, Shima T. (2011) Future directions of studies for recurrent miscarriage associated with immune etiologies. Journal of Reproductive Immunology 90: 91–95. - PubMed